Today, NuStar GP Holdings’ (NSH) Sell Rating Reaffirm at Credit Suisse Group AG

Today, NuStar GP Holdings’ (NSH) Sell Rating Reaffirm at Credit Suisse Group AG
Credit Suisse Group AG reaffirmed their sell rating on shares of NuStar GP Holdings, LLC (NYSE:NSH) in a research note issued to investors on Monday. They currently have a $25.00 price objective on the stock.

Several other research analysts have also recently commented on the stock. Citigroup Inc. raised shares of NuStar GP Holdings from a neutral rating to a buy rating and raised their target price for the stock from $26.00 to $29.00 in a report on Friday, August 12th. TheStreet cut shares of NuStar GP Holdings from a hold rating to a sell rating in a report on Friday, September 2nd. Zacks Investment Research raised shares of NuStar GP Holdings from a hold rating to a buy rating and set a $28.00 target price on the stock in a report on Wednesday, October 5th. Mizuho started coverage on shares of NuStar GP Holdings in a report on Thursday, September 29th. They set a neutral rating and a $26.00 target price on the stock. Finally, US Capital Advisors reaffirmed a hold rating on shares of NuStar GP Holdings in a report on Wednesday, September 21st. Two research analysts have rated the stock with a sell rating, five have given a hold rating and one has assigned a buy rating to the company. The stock has an average rating of Hold and an average price target of $25.67.

NuStar GP Holdings (NYSE:NSH) opened at 25.90 on Monday. The stock has a 50 day moving average price of $24.79 and a 200 day moving average price of $24.74. The firm has a market capitalization of $1.11 billion, a P/E ratio of 17.96 and a beta of 1.02. NuStar GP Holdings has a one year low of $12.86 and a one year high of $27.07.

NuStar GP Holdings (NYSE:NSH) last announced its earnings results on Wednesday, November 2nd. The company reported $0.40 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $0.36 by $0.04. On average, equities analysts predict that NuStar GP Holdings will post $1.53 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which was paid on Wednesday, November 16th. Shareholders of record on Tuesday, November 8th were given a $0.545 dividend. The ex-dividend date of this dividend was Friday, November 4th. This represents a $2.18 dividend on an annualized basis and a yield of 8.42%.

In other NuStar GP Holdings news, Director James F. Clingman sold 5,550 shares of the firm’s stock in a transaction that occurred on Wednesday, September 28th. The shares were sold at an average price of $25.35, for a total value of $140,692.50. Following the sale, the director now owns 40,947 shares in the company, valued at $1,038,006.45. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link.

A number of hedge funds have recently modified their holdings of the stock. WFG Advisors LP raised its stake in shares of NuStar GP Holdings by 50.6% in the second quarter. WFG Advisors LP now owns 11,900 shares of the company’s stock worth $305,000 after buying an additional 4,000 shares in the last quarter. Atlantic Trust Group LLC raised its stake in shares of NuStar GP Holdings by 9.2% in the second quarter. Atlantic Trust Group LLC now owns 1,126,260 shares of the company’s stock worth $28,878,000 after buying an additional 94,899 shares in the last quarter. Catalyst Capital Advisors LLC raised its stake in shares of NuStar GP Holdings by 59.3% in the second quarter. Catalyst Capital Advisors LLC now owns 162,076 shares of the company’s stock worth $4,156,000 after buying an additional 60,314 shares in the last quarter. Brown Advisory Securities LLC bought a new stake in shares of NuStar GP Holdings during the second quarter worth $254,000. Finally, Kayne Anderson Capital Advisors LP bought a new stake in shares of NuStar GP Holdings during the second quarter worth $2,822,000.

NuStar GP Holdings Company Profile

Related posts

Leave a Comment